FDA Inspection

Dana-Farber Cancer Institute, Office of Human Research Studies IRBFebruary 23, 2023

FDA Inspection 1201325 - Dana-Farber Cancer Institute, Office of Human Research Studies IRB - February 23, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Dana-Farber Cancer Institute, Office of Human Research Studies IRB, with an inspection on February 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Dana-Farber Cancer Institute, Office of Human Research Studies IRB
Inspection Date: February 23, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 5d5b4113-d7a9-4685-996e-e689863e550f